Related Experiment Video
Updated: Apr 3, 2026
Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
Published on: October 10, 2017
Predictive and Prognostic Value of the TauProtein in Breast Cancer
Claire Bonneau1, Zachary A Gurard-Levin2, Fabrice Andre3
1Department of Breast and Gynaecological Surgery, Curie Institute, Versailles-St-Quentin-en-Yvelines University, Versailles, France.
Background/Aim:
Predictive markers for response to chemotherapy are required in breast cancer. The Tau protein is a microtubule-associated protein variably expressed in breast cancer. The objective of our study was to describe drug resistance induced by the tau protein, and its predictive and prognostic value in breast cancer.
Materials And Methods:
Medline and PubMed databases were searched in April 2015 for terms "tau protein", "breast cancer", "chemotherapy sensitivity", "biomarker" and "taxane resistance".
Results:
In vitro, tau protein competes with taxane for controlling microtubule dynamic and loss of tau expression may render microtubules more vulnerable to the effects of taxanes. High tau protein expression was associated with better prognosis, even after adjustment for grade, hormone receptor and human epidermal growth factor receptor-2 expression, nodal status. The predictive value of the tau protein for sensitivity to taxane is discordant despite there being a trend for an association between low tau expression and increased response rate.
Conclusion:
Tau protein expression is insufficient for identifying a subset of patients with carcinomas that may benefit more from chemotherapy.
Related Concept Videos
01:16Kendall's Tau Test
A τ value of +1 indicates...
01:13Sensitivity, Specificity, and Predicted Value
Sensitivity is the...